$UNITREE
Unitree has priced its “toy” at 30,000 yuan, and the “big results” of Physical AI could be more impressive than anyone expects!
In October, Wang Xingxing changed his tune: the breakthrough in Physical AI went from “at most 10 years away” to “within the next 1 to 2 years.” JPMorgan promptly upgraded its rating on Unitree by two notches to “Overweight,” raising its target price from 300 yuan to 995 yuan. Its 2028 sales estimate jumped from 41,500 units to 111,500 units.
Prices offer even stronger evidence: the R1 bipedal humanoid robot was cut from 39,900 yuan to a starting price of 29,900 yuan, with units available for immediate purchase, and it topped JD.com’s sales rankings. The prospectus shows the average price of humanoid robots fell from 593,400 yuan in 2023 to 166,400 yuan in 2025—a drop of over 400,000 yuan in two years. Cumulative G1 production has reached 10,000 to 20,000 units, with shipments exceeding 5,500 units in 2025. The in-house development rate for core components is
over 90%.
But cracks are showing, too: Q3 revenue was 665 million yuan, up 69.93%, while net profit attributable to the parent company was just 113 million yuan, down 17.37% year on year. R&D expenses surged 249.58% in the quarter, and adjusted net profit for the first three quarters fell 18.78%. The company itself has warned that its trailing P/E ratio is 465 times, compared with an industry average of just 38.54 times.
Prices have fallen to a level within reach of ordinary people, and the breakthrough window has shortened from “ten years” to “one or two.” But if the big results do arrive, they will first show up in adjusted profits and repeat orders—not just in the share price.#宇树科技 #股票财报季
Unitree has priced its “toy” at 30,000 yuan, and the “big results” of Physical AI could be more impressive than anyone expects!
In October, Wang Xingxing changed his tune: the breakthrough in Physical AI went from “at most 10 years away” to “within the next 1 to 2 years.” JPMorgan promptly upgraded its rating on Unitree by two notches to “Overweight,” raising its target price from 300 yuan to 995 yuan. Its 2028 sales estimate jumped from 41,500 units to 111,500 units.
Prices offer even stronger evidence: the R1 bipedal humanoid robot was cut from 39,900 yuan to a starting price of 29,900 yuan, with units available for immediate purchase, and it topped JD.com’s sales rankings. The prospectus shows the average price of humanoid robots fell from 593,400 yuan in 2023 to 166,400 yuan in 2025—a drop of over 400,000 yuan in two years. Cumulative G1 production has reached 10,000 to 20,000 units, with shipments exceeding 5,500 units in 2025. The in-house development rate for core components is
over 90%.
But cracks are showing, too: Q3 revenue was 665 million yuan, up 69.93%, while net profit attributable to the parent company was just 113 million yuan, down 17.37% year on year. R&D expenses surged 249.58% in the quarter, and adjusted net profit for the first three quarters fell 18.78%. The company itself has warned that its trailing P/E ratio is 465 times, compared with an industry average of just 38.54 times.
Prices have fallen to a level within reach of ordinary people, and the breakthrough window has shortened from “ten years” to “one or two.” But if the big results do arrive, they will first show up in adjusted profits and repeat orders—not just in the share price.#宇树科技 #股票财报季
